These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4029014)

  • 21. Effect of renal function and dialysis on temocillin pharmacokinetics.
    Boelaert J; Daneels R; Schurgers M; Mellows G; Swaisland AJ; Lambert AM; Van Landuyt HW
    Drugs; 1985; 29 Suppl 5():109-13. PubMed ID: 4029012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temocillin pharmacokinetics in normal and impaired renal function.
    Höffler D; Koeppe P
    Drugs; 1985; 29 Suppl 5():135-9. PubMed ID: 4029017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temocillin in the treatment of gram-negative septicaemia.
    Van Landuyt HW; Lambert A; Van Couter A; Boelaert J
    Drugs; 1985; 29 Suppl 5():182-5. PubMed ID: 3896738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temocillin in the treatment of pyelonephritis in children.
    Verboven M; Lauwers S; Pintens H
    Drugs Exp Clin Res; 1987; 13(3):171-3. PubMed ID: 3622246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and tissue penetration of temocillin.
    Lockley MR; Brown RM; Wise R
    Drugs; 1985; 29 Suppl 5():106-8. PubMed ID: 4029011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical and pharmacokinetics studies of ceftriaxone upon 2g once daily administration in respiratory tract infections].
    Ishioka S; Yamakido H; Inyaku K; Hasegawa K; Yamakido M; Akagawa T; Kuwabara M; Kodomari Y; Kawamoto M; Arita H
    Jpn J Antibiot; 1991 Jun; 44(6):605-13. PubMed ID: 1890721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic experience with temocillin in peritonitis.
    Pfeiffer M; Fock RR
    Drugs; 1985; 29 Suppl 5():194-6. PubMed ID: 3896740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication.
    Peloquin CA; Cumbo TJ; Nix DE; Sands MF; Schentag JJ
    Arch Intern Med; 1989 Oct; 149(10):2269-73. PubMed ID: 2508586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung tissue penetration of temocillin.
    Cowan W; Baird A; Sleigh JD; Gray JM; Leiper JM; Lawson DH
    Drugs; 1985; 29 Suppl 5():151-3. PubMed ID: 4029020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temocillin in cystic fibrosis: a retrospective pilot study.
    Kent L; Bradley JM; France M; Döring G; Carryn S; Bradbury I; Rendall J; Jones A; Elborn JS
    J Cyst Fibros; 2008 Nov; 7(6):551-4. PubMed ID: 18706868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amoxycillin: a preliminary report of its pharmokinetic properties and therapeutic efficacy.
    Brogden RN; Speight TM; Avery GS
    Drugs; 1974; 7(5):326-36. PubMed ID: 4604079
    [No Abstract]   [Full Text] [Related]  

  • 32. Temocillin dosage adjustment in a preterm infant with severe renal disease: a case report.
    Dumangin G; Brenkman M; Pape E; Kolodziej A; Gambier N; Vrillon I; Charmillon A; Scala-Bertola J
    J Antimicrob Chemother; 2020 Dec; 75(12):3652-3655. PubMed ID: 32814946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
    Colardyn F
    J Chemother; 1995 Jun; 7 Suppl 2():129-35. PubMed ID: 8622101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temocillin in the treatment of Burkholderia cepacia infection in cystic fibrosis.
    Lekkas A; Gyi KM; Hodson ME
    J Cyst Fibros; 2006 May; 5(2):121-4. PubMed ID: 16650744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of temocillin in urinary tract infections.
    Asbach HW; Becker-Boost E; Melekos MD
    Drugs; 1985; 29 Suppl 5():175-7. PubMed ID: 3896736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temocillin in peripheral lymph.
    Bergan T; Engeset A; Olszewski W
    J Antimicrob Chemother; 1983 Jul; 12(1):59-63. PubMed ID: 6619047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical studies of cefoxitin for the treatment of chronic respiratory tract infections (author's transl)].
    Asakawa M; Yoshida U; Harada T; Shimazu T
    Jpn J Antibiot; 1981 Feb; 34(2):205-10. PubMed ID: 7253200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temocillin efficacy in experimental Klebsiella pneumoniae meningitis after infusion into rabbit plasma to simulate antibiotic concentrations in human serum.
    Woodnutt G; Catherall EJ; Kernutt I; Mizen L
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1705-9. PubMed ID: 3252752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The place of temocillin in the treatment of hospital infections.
    Williams JD; Chen HY
    Drugs; 1985; 29 Suppl 5():234-9. PubMed ID: 3875473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.